News Releases

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

December 10, 2024

VisiRose, a clinical-stage biotechnology company, is introducing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a groundbreaking, non-invasive investigational treatment for infectious keratitis and other serious eye infections developed by the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute (BPEI).

Bascom Palmer Eye Institute Ranked Nation's No. 1 in Ophthalmology for 23rd Time

Bascom Palmer Eye Institute Ranked Nation's No. 1 in Ophthalmology for 23rd Time

March 27, 2024

For the 23rd time, Bascom Palmer Eye Institute, part of the University of Miami Health System and the University of Miami Miller School of Medicine, has been ranked the nation’s Best in Ophthalmology by U.S. News & World Report in its annual Best Hospitals survey.

Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium

Provectus Biopharmaceuticals Announces Exclusive Worldwide License Agreement with University of Miami for Photodynamic Antimicrobial Treatment of Different Eye Infections with Rose Bengal Sodium

July 16, 2024

New Provectus Spinout Company Would Commercialize Combination Therapy of University’s Light Source Medical Device and Provectus’s Pharmaceutical-Grade Rose Bengal Sodium